About Cytokinetics
Cytokinetics is a company based in San Francisco (United States) founded in 1997.. Cytokinetics has raised $60 million across 11 funding rounds from investors including Morgan Stanley, Duke University and HHS. The company has 498 employees as of December 31, 2024. Cytokinetics offers products and services including Cardiac Myosin Inhibitors and Muscle Activators. Cytokinetics operates in a competitive market with competitors including AskBio, BioAge Labs, Solid Biosciences, Kate Therapeutics and Epirium Bio, among others.
- Headquarter San Francisco, United States
- Employees 498 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytokinetics, Incorporated
-
Annual Revenue
$18.47 M145.34as on Dec 31, 2024
-
Net Profit
$-589.53 M-12.03as on Dec 31, 2024
-
EBITDA
$-526.72 M-8.76as on Dec 31, 2024
-
Total Equity Funding
$60 M (USD)
in 11 rounds
-
Latest Funding Round
$450 M (USD), Post-IPO
Jul 01, 2022
-
Investors
Morgan Stanley
& 5 more
-
Employee Count
498
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cytokinetics
Cytokinetics is a publicly listed company on the NASDAQ with ticker symbol CYTK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cytokinetics
Cytokinetics offers a comprehensive portfolio of products and services, including Cardiac Myosin Inhibitors and Muscle Activators. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Inhibitors targeting heart failure and hypertrophic cardiomyopathy treatments
Activators for neuromuscular disease management and function improvement
Unlock access to complete
Unlock access to complete
Leadership Team
97 people
Software Development Team
29 people
Operations Team
23 people
Sales and Marketing
18 people
Senior Team
18 people
Product Management Team
14 people
Finance and Accounting
12 people
Scientific Team
11 people
Unlock access to complete
Funding Insights of Cytokinetics
Cytokinetics has successfully raised a total of $60M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $450 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $450.0M
-
First Round
First Round
(12 Oct 1999)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Post-IPO - Cytokinetics | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Cytokinetics | Valuation |
investors |
|
| Nov, 2019 | Amount | Post-IPO - Cytokinetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cytokinetics
Cytokinetics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Morgan Stanley, Duke University and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are facilitated by Amgen-backed entity.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early-stage US investments in technology and offline sectors are targeted.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cytokinetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cytokinetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytokinetics Comparisons
Competitors of Cytokinetics
Cytokinetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AskBio, BioAge Labs, Solid Biosciences, Kate Therapeutics and Epirium Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform for Duchenne muscular dystrophy is developed.
|
|
| domain | founded_year | HQ Location |
AAV-based gene therapies for muscle diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for cancer via mitochondrial biogenesis are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytokinetics
Frequently Asked Questions about Cytokinetics
When was Cytokinetics founded?
Cytokinetics was founded in 1997 and raised its 1st funding round 2 years after it was founded.
Where is Cytokinetics located?
Cytokinetics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Cytokinetics a funded company?
Cytokinetics is a funded company, having raised a total of $60M across 11 funding rounds to date. The company's 1st funding round was a Post-IPO of $138M, raised on Oct 12, 1999.
How many employees does Cytokinetics have?
As of Dec 31, 2024, the latest employee count at Cytokinetics is 498.
What is the annual revenue of Cytokinetics?
Annual revenue of Cytokinetics is $18.47M as on Dec 31, 2024.
What does Cytokinetics do?
Cytokinetics was founded in 1997 and is headquartered in San Francisco, United States. Operations focus on the biotechnology sector, where muscle activators are developed as treatments for conditions such as heart failure and spinal muscular atrophy. The drug pipeline includes omecamtiv mecarbil, a cardiac myosin activator investigated in collaboration with Amgen, and CK-2127107, a skeletal muscle troponin activator targeted at SMA patients.
Who are the top competitors of Cytokinetics?
Cytokinetics's top competitors include AskBio, Solid Biosciences and BioAge Labs.
What products or services does Cytokinetics offer?
Cytokinetics offers Cardiac Myosin Inhibitors and Muscle Activators.
Is Cytokinetics publicly traded?
Yes, Cytokinetics is publicly traded on NASDAQ under the ticker symbol CYTK.
Who are Cytokinetics's investors?
Cytokinetics has 6 investors. Key investors include Morgan Stanley, Duke University, HHS, Amgen Business Development, and Vulcanventuresinvestments.com.
What is Cytokinetics's ticker symbol?
The ticker symbol of Cytokinetics is CYTK on NASDAQ.